A screening method known as untargeted metabolomics profiling can diagnose inborn errors of metabolism in a group of rare genetic conditions seven times higher than the traditional metabolic screening method. A new study by researchers at Baylor College of Medicine demonstrates that untargeted metabolomics can identify many varieties of disorders compared to traditional methods. This method can be used even for disorders without clinical biochemical test.
‘New untargeted metabolomics screening approach improves the diagnosis of metabolic disorders in newborns.’
Tweet it Now
Adopting metabolomics to screen for inborn errors of metabolism will result in a more rapid, efficient and less expensive diagnostic procedure for individuals and families with rare metabolic disorders."Currently, new-born screening is conducted in every infant born in the U.S. to check for serious but rare health conditions at birth. Screening includes blood, hearing and heart tests”, said corresponding author Dr. Sarah Elsea, professor of molecular and human genetics at Baylor and senior director of biochemical genetics at Baylor Genetics.
Inborn errors of metabolism are conditions that disrupt the normal processes the body uses to transform food into energy and can result in serious conditions. So, having an early diagnosis can lead to early treatment as soon as possible.
The researchers compared the results of applying the two approaches to 4,464 clinical samples received from 1,483 unrelated families. They discovered that the traditional standard analysis has a positive rate of diagnosis of about 1% but the untargeted metabolomics analysis has a positive rate of diagnosis of about 7%.
Analyzing many metabolic compounds in a single blood sample reduces the need of having more samples to do further testing for specific conditions and the time period between diagnosis and starting of treatment.
Advertisement
This novel broader screening approach identifies severe forms and also mild forms of disease that may not fit the characteristics observed in the more severe cases.
Advertisement
Source-Medindia